Skip to Content
Merck
  • Dynamic Regulation of SARS-Cov-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular Myocardium.

Dynamic Regulation of SARS-Cov-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular Myocardium.

JACC. Basic to translational science (2020-08-25)
Michael R Bristow, Lawrence S Zisman, Natasha L Altman, Edward M Gilbert, Brian D Lowes, Wayne A Minobe, Dobromir Slavov, Jessica A Schwisow, Erin M Rodriguez, Ian A Carroll, Thomas A Keuer, Peter M Buttrick, David P Kao
ABSTRACT

Using serial analysis of myocardial gene expression employing endomyocardial biopsy starting material in a dilated cardiomyopathy cohort, we show that mRNA expression of the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) cardiac myocyte receptor ACE2 is up-regulated with remodeling and with reverse remodeling down-regulates into the normal range. The proteases responsible for virus-cell membrane fusion were expressed but not regulated with remodeling. In addition, a new candidate for SARS-CoV-2 cell binding and entry was identified, the integrin encoded by ITGA5. Up-regulation in ACE2 in remodeled left ventricles may explain worse outcomes in patients with coronavirus disease 2019 who have underlying myocardial disorders, and counteracting ACE2 up-regulation is a possible therapeutic approach to minimizing cardiac damage.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
5-Nitro-2-(3-phenylpropylamino)benzoic acid, ≥98%